Journalism of Courage
Advertisement
Prabha Raghavan
Authors you can follow
More From Prabha Raghavan - Page 6
UK clears Oxford shot, regulatory panel considers nod in India tooSubscriber Only
December 31, 2020 04:04 IST
Following the nod for the vaccine in the UK, a subject expert committee (SEC) of the Indian regulator was considering a request from SII for similar approval in India under emergency circumstances, a senior government official said.
Thu, Dec 31, 2020
‘Vaccine price to be outcome of scale; have output capacity of 30 mn doses per month’Subscriber Only
December 26, 2020 05:53 IST
In an interview to PRABHA RAGHAVAN, Singh details how the Pune firm’s vaccine works and delves into plans to test and scale up production for a vast population. Edited excerpts:
Sat, Dec 26, 2020
Electricity (Rights of Consumers) Rules, 2020: Norms bring in compensation mechanismSubscriber Only
December 23, 2020 03:02 IST
This is because the provisions make distribution companies more accountable to consumers.
Wed, Dec 23, 2020
Electricity Rules: Timely connection, 24×7 supply; fines in place for discomsSubscriber Only
December 22, 2020 03:00 IST
According to the Ministry, the move was “necessary” because distribution companies, regardless of whether they are public or private, are “monopolies”, and the consumer has no alternative.
Tue, Dec 22, 2020
Adar Poonawalla: Need govt to indemnify vaccine makers against all lawsuitsSubscriber Only
December 19, 2020 02:24 IST
According to Poonawalla, when “frivolous” claims crop up and are blown out of proportion, it affects the confidence of not just anti-vaxxers, but the general public too.
Sun, Dec 20, 2020
Explained: What is currency manipulation, and why has US put India on its currency watchlist?Subscriber Only
December 17, 2020 13:32 IST
The designation of a country as a currency manipulator does not immediately attract any penalties, but tends to dent the confidence about a country in the global financial markets.
Wed, Dec 23, 2020
Pune-based Gennova to begin human trials of its Covid vaccine ‘soon’Subscriber Only
December 15, 2020 02:13 IST
"For phase 1, we have got two sites where we will be starting enrolment soon," he said, adding that around 120 volunteers will be registered in the first phase at two sites -- KEM Hospital, Pune and a government hospital in Kolhapur.
Tue, Dec 15, 2020
Panel seeks more vaccine data before emergency nodSubscriber Only
December 10, 2020 02:42 IST
Serum, Bharat Biotech to give safety, efficacy details; Pfizer wants time
Thu, Dec 10, 2020
With data from UK and India, Covishield and Covaxin go to regulatorSubscriber Only
December 08, 2020 04:30 IST
Bharat Biotech submitted its application to the drug regulator late on Monday evening, the sources said, becoming the third company after American pharma giant Pfizer and Pune-based Serum Institute of India (SII) to seek emergency use authorisation for its Covid-19 vaccine candidate.
Tue, Dec 08, 2020Vial manufacturers prepare to ramp up capacity, govt still unclear on demandSubscriber Only
December 07, 2020 01:51 IST
Given that the vaccines will likely be filled in multidose vials, industry executives feel this demand will easily be met.
Mon, Dec 07, 2020
Explained: What is the intellectual property MoU between India and the US, and how will it help?Subscriber Only
December 04, 2020 13:46 IST
India and the US this week signed a Memorandum of Understanding (MoU) on intellectual property cooperation. What is it about? How will it increase IP cooperation between India and the US? How will it be implemented?
Fri, Dec 04, 2020
Explained: What is emergency use authorisation firms are seeking for Covid-19 vaccines?Subscriber Only
December 01, 2020 09:29 IST
Coronavirus vaccines: Pfizer has applied for emergency use authorisation of its vaccine; Moderna and Serum Institute of India too plan to apply to the respective authorities. What is the process, and how is it different from full approval?
Thu, Dec 10, 2020
An Expert Explains: India’s road to mass vaccination against Covid-19Subscriber Only
November 30, 2020 04:05 IST
Once a Covid-19 vaccine becomes available in India, how does the government go about immunising the population? Which groups should get the vaccine first, and who should get it free?
Sat, Dec 05, 2020
Hetero to manufacture 100 million doses of Sputnik V for IndiaSubscriber Only
November 27, 2020 12:09 IST
Sputnik V is also expected to be tested in mid- to late-stage clinical trials in India by Dr Reddy's Laboratories, another Hyderabad-headquartered drugmaker.
Fri, Nov 27, 2020
Explained: Here are the key takeaways from Oxford’s Covid-19 vaccine errorSubscriber Only
November 27, 2020 03:20 IST
After trial results of the AstraZeneca-Oxford vaccine, it has now emerged that a mistake in dosing led to the 90% efficacy report. What questions does this raise about this vaccine, and about trials in general?
Thu, Dec 03, 2020
More tests likely for SII to get to Oxford’s half-dose efficacySubscriber Only
November 26, 2020 05:37 IST
Dr Cyrus Poonawalla, told The Indian Express on Monday that it would be asking the Central Drugs Standard Control Organisation (CDSCO) for “special emergency marketing authorisation” for Covishield in 45 days.
Thu, Nov 26, 2020
Explained: How far are we from a Covid-19 vaccine? When will India get it?Subscriber Only
November 24, 2020 04:08 IST
AstraZeneca Oxford vaccine trials put efficacy at 62% when two full doses are given, and 90% when first shot is half a dose. How does it compare to other vaccines, and what does it mean for Covishield in India?
Tue, Dec 01, 2020
Where are we in the Covid-19 vaccine hunt? Dr Gagandeep Kang explainsSubscriber Only
November 23, 2020 06:34 IST
Covid-19 Vaccine: The last two weeks have seen a string of encouraging results from coronavirus vaccine trials. What do these findings mean, what questions remain, and what does India need for a mass vaccination exercise?
Mon, Nov 30, 2020Could seek govt nod for limited use of ‘Covishield’ in December, may cost Rs 500-600: Serum CEOSubscriber Only
November 20, 2020 04:35 IST
Coronavirus vaccine price: Covishield is the name in India of the Covid-19 vaccine candidate developed by the University of Oxford and AstraZeneca. Promising results about the effectiveness of the candidate in vulnerable age groups were published in The Lancet on Thursday.
Fri, Nov 20, 2020
India US ties: Under Biden, less acrimonious trade ties likely; sticking points may remainSubscriber Only
November 18, 2020 00:39 IST
While Joe Biden's term as president is expected to bring the US back into various multilateral forums, experts aren’t entirely sure what his term could mean for bilateral trade ties.
Wed, Nov 18, 2020
Moderna says Covid vaccine 95% effective; may be promising option in IndiaSubscriber Only
November 17, 2020 04:32 IST
Last week, Pfizer-BioNTech and the Russian makers of the Sputnik V vaccine announced that their candidates had been found to be over 90 per cent effective in preliminary results of phase 3 human trials.
Tue, Nov 17, 2020
Study on benefits, costs helped govt firm up RCEP standSubscriber Only
November 17, 2020 04:26 IST
Where RCEP members are concerned, India’s deficits have marginally reduced in most cases. However, its total deficit with ASEAN as a bloc has increased between 2018-19 and 2019-20, according to data from the Ministry of Commerce and Industry.
Tue, Nov 17, 2020
Explained: The economic implications of India opting out of RCEPSubscriber Only
November 17, 2020 01:19 IST
The regional trade agreement has been signed by 15 countries, without India. A look at the factors leading to India opting out, how China’s aggression firmed the decision, and the economic implications of the move.
Thu, Nov 26, 2020RCEP: Door still open for India, may take part in meets as ‘observer’Subscriber Only
November 16, 2020 01:48 IST
While India had been involved in RCEP negotiations since 2013, it walked out of the pact last year citing “significant outstanding issues” that were unresolved by the deadline to enter the agreement.
Mon, Nov 16, 2020
Auto to tech, 10 more sectors to gain from hike in PLI allocationSubscriber Only
November 12, 2020 02:41 IST
The PLI scheme for these ten sectors will be operational for five years with a total estimated outlay of Rs 1.45 lakh crore.
Thu, Nov 12, 2020Journalism of Courage
Install the Express App for
a better experience
a better experience
Featured
Trending Topics
News
Multimedia
Follow Us